Mariana Biscaia-Caleiras

Mariana Biscaia-Caleiras

Auto-generated profile, based on publicly available information

Mariana Biscaia-Caleiras

CNC-UC - Center for Neurosciences and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Faculty of Medicine (Polo 1), Rua Larga, 3004-504, Coimbra, Portugal; Bluepharma - Indústria Farmacêutica, S.A., São Martinho do Bispo, 3045-016, Coimbra, Portugal; Univ Coimbra - University of Coimbra, CIBB, Faculty of Pharmacy, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
ACAna F. Cruz
Ana F. Cruz
MCMariana B. Caleiras
Mariana B. Caleiras
NFNuno A. Fonseca
Nuno A. Fonseca
NGNélio Gonçalves
Nélio Gonçalves
VMVera Mendes
Vera Mendes
João Nuno MoreiraJoão Nuno Moreira
João Nuno Moreira
Targeting multiple cellular populations is of high therapeutic relevance for the tackling of solid tumors heterogeneity. Herein, the ability of pegylated and pH-sensitive liposomes, functionalized with the nucleolin-binding F3 peptide and containing doxorubicin (DXR)/C6-ceramide synergistic combination, to target, in vitro, ovarian cancer, including ovarian cancer stem cells (CSC), was assessed. The underlying molecular mechanism of action of the nucleolin-mediated intracellular delivery of C6-ceramide to cancer cells was also explored. The assessment of overexpression of surface nucleolin expression by flow cytometry was critical to dissipate differences identified by Western blot in membrane/cytoplasm of SKOV-3, OVCAR-3 and TOV-112D ovarian cancer cell lines. The former was in line with the significant extent of uptake into (bulk) ovarian cancer cells, relative to non-targeted and non-specific counterparts. This pattern of uptake was recapitulated with putative CSC-enriched ovarian SKOV-3 and OVCAR-3 sub-population (EpCAMhigh/CD44high). Co-encapsulation of DXR:C6-ceramide into F3 peptide-targeted liposomes improved cytotoxic activity relative to liposomes containing DXR alone, in an extent that depended on the intrinsic resistance to DXR and on the incubation time. The enhanced cytotoxicity of the targeted combination was mechanistically supported by the downregulation of PI3K/Akt pathway by C6-ceramide, only among the nucleolin-overexpressing cancer cells presenting a basal p-Akt/total Akt ratio lower than 1.

3 October 2025 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
MBMariana Biscaia-Caleiras
Mariana Biscaia-Caleiras
ALAna Sofia Lourenço
Ana Sofia Lourenço
João Nuno MoreiraJoão Nuno Moreira
João Nuno Moreira
SSSérgio Simões
Sérgio Simões

15 February 2025 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
MBMariana Biscaia-Caleiras
Mariana Biscaia-Caleiras
NFNuno Fonseca
Nuno Fonseca
ALAna Sofia Lourenço
Ana Sofia Lourenço
ANAntonio Nunes
Antonio Nunes
AFAbel Ferreira
Abel Ferreira
SSSérgio Simões
Sérgio Simões